Europe’s Deep Tech Paradox: World-Class Science, Invisible Companies
In this article, Dr. Peter M. Kovacs draws on his discussion with Thijmen Meijer and Károly Szántó to explain why Europe’s startup gap is not a capital shortage but a translation failure, and sets out what must change to convert scientific excellence into globally competitive deep-tech companies.
Work Ability Is the New KPI: A Leadership System, Not an HR Program
In this article, Dr. Peter M. Kovacs explains why age management isn’t an HR trend but a CEO responsibility: measure work ability with the Work Ability Index, confront what’s eroding performance, and redesign work across life stages.
Investing in Healthcare in an Age of Hype: Why Skepticism, Simplicity, and Human Judgment Matter More Than Ever
In this article, Dr. Peter M. Kovacs explores why the biggest risks in healthcare investing aren’t scientific but psychological. Drawing on a conversation with investor Ales Vavra, he examines hope, AI, due diligence, and the discipline required to invest responsibly in health.
The Hard Way Is the Only Way: What Alzheimer’s Care Taught Me About AI, Trust, and Real Innovation
In this article, Peter shares what Alzheimer’s care taught him about AI: trust is earned through evidence, regulation, and human-centered design. A conversation with Peter Markus (Kompanion Care) shows why the “hard way” is the only path to real innovation.
AI in Hospitals Is Not a Technology Challenge. It’s a Leadership One
In this article, Peter argues that AI in hospitals isn’t a radiology or technology challenge but a leadership one. Drawing on insights from Antonín Hlavinka, he shows why governance, procurement, data residency, and workforce design determine real AI impact.
The Last Sense We Lose: Why Voice, Dignity, and Human Connection Will Define the Future of Aging
Peter M. Kovacs explores aging, loneliness, and ethical AI, arguing that voice technology, dignity, and human connection are essential to preserving identity, legacy, and independence for seniors in a rapidly aging society.
From Chemistry Passion to Clinical Impact: How CROs Must Evolve to Power the Next Generation of Biotech Innovation
Dr. Peter M. Kovacs interviews Jiri Raska of Quinta Analytica on how CROs support biotech startups through biologics, bioequivalence trials, ADC analytics, and Europe’s evolving clinical trial regulations.
The Power of Value: How One MedTech Leader Navigated Transformation, AI Disruption, and the Future of Innovation
A deep look into Jiri Pavlicek’s leadership philosophy revealing how values, courage, and conscious execution shape the future of European MedTech and AI innovation. Why founders who master mindset outperform those who chase technology alone.